First-line treatment of advanced gastric cancer and hepatic dysfunction with oxaliplatin, 5-fluorouracil and cetuximab.
Clin Transl Oncol
; 10(3): 182-4, 2008 Mar.
Article
em En
| MEDLINE
| ID: mdl-18321823
ABSTRACT
There is no standard chemotherapy regimen in advanced gastric cancer with poor performance status and hepatic dysfunction. New chemotherapeutical agents and targeted therapy have demonstrated promising results in terms of efficacy and safety in phase II clinical trials. We report the case of a 68-year-old man with stage IV gastric cancer and severe hepatic dysfunction due to liver metastases treated with a combination of oxaliplatin, 5-fluorouracil and cetuximab.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Gástricas
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Hepatopatias
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
Clin Transl Oncol
Ano de publicação:
2008
Tipo de documento:
Article
País de afiliação:
Espanha